The Risk of QTc Prolongation in Non-Diabetic and Diabetic Patients Taking Tyrosine Kinase Inhibitors (TKIs)- A Patient Safety Project at a Private Oncology Practice

Objective: To assess the prevalence of QTc prolongation in both non-diabetic and diabetic patients on TKIs. Some TKIs have been reported to cause QTc prolongation, which is prevalent in diabetes. However, there is no Risk Evaluation and Mitigation Strategy using series ECG to monitor those patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Zhongju, Luu, Ying, Ip, Jack, Husain, Imran, Lu, Michael, Kim, Chang-Kyung, Yang, Peng, Chu, David, Lin, Richard, Cohen, Ira, Kaell, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604509/
https://www.ncbi.nlm.nih.gov/pubmed/34804394
http://dx.doi.org/10.1080/20009666.2021.1978652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604509/
https://www.ncbi.nlm.nih.gov/pubmed/34804394
http://dx.doi.org/10.1080/20009666.2021.1978652

Ejemplares similares